Open Rank (Assistant/Associate/Full Professor) - Biomanufacturing Bookmark this Posting Print Preview | Apply for this Job Please see Special Instructions for more details. To apply applicants should go to https://uta.peopleadmin.com/postings/33952 and submit the following materials:Curriculum VitaeCover/Interest LetterUnofficial Transcripts (required for candidates for whom their degree is not in the same discipline
as the one in which they will teach)Statement of Research InterestsStatement of Teaching Interest/PhilosophyContact Information for 3 to 5 referencesThe priority deadline for review is October 19, 2026 at 11:59PM.Questions may be addressed to Katherine Flannery at katherine.flannery2@uta.edu for any questions.For more information about UTA, please visit: http://www.uta.edu/uta. Posting Details Position Information
Posting Number F00805P Position Title Open Rank (Assistant/Associate/Full Professor) - Biomanufacturing Department Provost Office Location Arlington Job Family Faculty Position Status Full-time Rank Open-T/TT Work Hours Standard Open to External and Internal FLSA Exempt Duration Funding expected to continue Pay Basis Monthly Benefits Eligible Yes Job Summary The University of Texas at Arlington (UTA) invites
applications for five tenure-track faculty positions as part of a coordinated faculty cluster hire designed to establish a nationally distinctive HLA-Peptide Biotherapeutics Program within the Institute of Biomanufacturing and Precision Medicine for North Texas (IMPRINT). These positions represent a single integrated hiring initiative rather than five independent searches. Successful candidates will join a
collaborative research ecosystem focused on translating disease-selective HLA-peptide targets into novel biotherapeutic products through a seamless discovery-to-translation framework. This initiative is led by Dr. Jon A. Weidanz, Senior Associate Vice President for Research & Innovation and Founding Director of IMPRINT. The program builds upon established strengths in HLA biology, immunopeptidomics, HLA-E biology,
peptide-MHC recognition, and TCR-mimic (TCRm) antibody discovery and engineering. The cluster is centered on the scientific premise that intracellular disease biology can be therapeutically targeted through disease-selective peptide-HLA complexes displayed on the cell surface. By integrating target discovery, molecular recognition, therapeutic engineering, manufacturing science, and translational development, IMPRINT
Summary from the source posting. Always confirm details on the institution's official career page.